This inventor holds 3 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 7 EPO patents. Top assignees: Cugene Inc., Amgen Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Jing Xu in Cytokine-Based Therapeutics
Introduction
Jing Xu is an accomplished inventor based in Waltham, MA (US), known for his significant contributions to the field of cytokine-based therapeutics. With a total of 3 patents, his work focuses on developing innovative drug constructs aimed at improving treatment outcomes for various diseases.
Latest Patents
One of his latest patents is centered around a cytokine-based bioactivatable drug construct known as the 'VitoKine' platform. This innovative platform is designed to reduce systemic mechanism-based toxicities while enhancing the therapeutic utility of proteins and cytokines such as IL-15 and IL-2. The VitoKine constructs include a tissue or disease site targeting moiety, a bioactivatable moiety, and a concealing moiety. This design ensures that the active moiety remains inert until activated locally by proteases in diseased tissues, thereby minimizing undesirable toxicities and improving therapeutic efficacy.
Another notable patent involves novel IL-15 fusion proteins that are intended for the treatment of cancer and other disorders. These fusion proteins consist of an IL-15/IL-15RαSushi domain and an Fc domain, which work together to extend the half-life of IL-15 in vivo. This advancement addresses limitations observed in previous IL-15 therapeutics and demonstrates superior preclinical activity compared to existing treatments.
Career Highlights
Jing Xu has worked with prominent companies in the biotechnology sector, including Cugene Inc. and Amgen Inc. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.
Collaborations
Throughout his career, Jing has collaborated with notable professionals in the field, including Yue-Sheng Li and Lingyun Rui. These collaborations have further enriched his research and development efforts.
Conclusion
Jing Xu's innovative work in cytokine-based therapeutics showcases his commitment to advancing medical science and improving patient outcomes. His patents reflect a deep understanding of the complexities of disease treatment and a dedication to creating safer and more effective therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile